In the BioHarmony Drug Report Database
Pindolol
Visken (pindolol) is a small molecule pharmaceutical. Pindolol was first approved as Visken on 1982-09-03. It is used to treat angina pectoris, hypertension, and myocardial infarction in the USA. The pharmaceutical is active against beta-2 adrenergic receptor and beta-1 adrenergic receptor. In addition, it is known to target 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2A, and 5-hydroxytryptamine receptor 1B.
Trade Name
|
Visken |
|---|---|
Common Name
|
pindolol |
ChEMBL ID
|
CHEMBL500 |
Indication
|
angina pectoris, hypertension, myocardial infarction |
Drug Class
|
Beta-blockers (propranolol type) |
Image (chem structure or protein)